Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mast Therapeutics, Inc.

https://savarapharma.com/

Latest From Mast Therapeutics, Inc.

EMA Recommends Stemline’s Elzonris After Initial Rejection

While the European Medicine Agency now recommends that Elzonris should be approved in the EU, Stemline Therapeutics will have to submit the results of a study based on a registry of patients with blastic plasmacytoid dendritic cell neoplasm.

Europe Approvals

Strides Begins Biosimilar Filings With Teriparatide

Strides files for a biosimilar to Eli Lilly’s Forteo (teriparatide) in the EU, marking the beginning of its journey in the biosimilars segment. Meanwhile, it hopes to enter a manufacturing tie-up with COVID-19 vaccine players in H2 while also planning a launch of favipiravir in markets outside India.

Biosimilars Strategy

Strides Begins Biosimilar Filings With Teriparatide

Strides files for a biosimilar to Eli Lilly’s Forteo (teriparatide) in the EU, marking the beginning of its journey in the biosimilars segment. Meanwhile, it hopes to enter a manufacturing tie-up with COVID-19 vaccine players in H2 while also planning a launch of favipiravir in markets outside India.

Commercial Biosimilars

Keeping Track Of Breakthroughs: AZ Farxiga, ImmunoGen ADC For Hematologic Cancer, Inventiva NASH Candidate Earn Designation

The latest breakthrough therapy designation news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Review Pathway Cancer
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Other Names / Subsidiaries
    • Adventrx Pharmaceuticals, Inc.
    • Aires Pharmaceuticals, Inc.
    • SynthRx, Inc.
UsernamePublicRestriction

Register